1.Immunohistochemical and Ultrastructural Cellular Differentiation in Papillary and Solid Epithelial Neoplasm of the Pancreas.
Jae Hyuck LEE ; Min Cheol LEE ; Chang Soo PARK ; Kyu Hyuk CHO
Korean Journal of Pathology 1992;26(1):40-52
Papillary and solid epithelial neoplasm of the pancreas from five patients were studied using immunohistochemistry and electron microscopy to define the cellular origin of this type of tumor. The tumors ranged in diameter form 5.5 to 15 cm Grossly, these were well circumscribed by a firm, gray-white, fibrous capsule and their cut-surface showed mainly area containing mucinous substance with necrotic and hemorrhagic material, with some solid portion. Microscopically, there was a solid and papillary pattern, with uniform cells typically having round to ovoid nuclei containing indistinct nucleoli and eosinophilic, granular cytoplasm. Within the cytoplasm of the tumor cells, numerous PAS-positive granules were found. Immunostaining was positive for neuron-specific enolase(three of five cases), alpha1-antitrypsin and alpha1-antichymotrypsin(three of five cases) in the solid and papillary portion of the tumor. But no polypeptide hormone immunoreactive cells were present in all cases except for gastrin which showed focally weak positivity in the papillary area. Ultrastructurally, the papillary and solid epithelial neopasm of the pancreas showed evidence of acinar cell differentiation, because in the cell of one observed some zymogen-like granules and presence of annulate lamellae. But also, abundant typical neurosecretory granules were detected in the tumor cells ultrastructurally. Both facts suggested acinar and islet cell differentiation of the tumor. From the these findings, it concluded that papillary and solid epithelial neoplasm of the pancreas may be originated from a primordial cell which will be able to render both endocrine and exocine component.
2.The effectiveness of endometrial thickness for prediction of implantation in IVF & ET.
Hyuck Chan KWON ; Dong Jae CHO ; Ki Seok OH ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1993;36(12):3912-3919
No abstract available.
3.Comparative Analysis of Neurologic Recovery with or without Laminectomy in the Treatment of Thoracic and Lumbar Fractures with Neurologic Symptoms.
Soon Taek JUNG ; Hae Ryong SONG ; Jae Boem NA ; Hyung Bin PARK ; Jae Hyuck JEONG ; Se Hyun CHO
The Journal of the Korean Orthopaedic Association 1998;33(5):1334-1343
Recently there has been a progressive increase of thoracolumbar fractures with neurologic symptoms. It has been thought that laminectomy increased instability and was therefore considered a contraindication. Currently, with the development of instrument for posterior stabilization, it is possible to perform posterior fusion and instrumentation, both with and without laminectomy. To compare the effect of neurologic recovery with and without laminectomy, we analyzed the clinical records of 38 patients with neurologic symptoms who were evaluated with plain radiographs and CT before and after surgery from 1989 to 1996 in Gyeong-Sang National University Hospital. We divided our cases into two groups, one group consisted open reduction with laminectomy and instrumentation with posterior fusion. The other group consisted of open reduction without laminectomy and instrumentation with posterior fusion. Twenty three of 38 were operated with open reduction and internal fixation with laminectomy and others were operated without laminectomy. The results were that both groups had improvement of neurologic symptoms after surgery and at follow-up. There was no significant statistical difference between the two groups. Depending on the time interval between injury and surgery, patients who were underwent emergency surgery had an marked improvement of neurologic symptoms. Except cases of complete paraplegia, incomplete paraplegic patients who were operated within 24 hours with laminectomy group had greater improvement than those without laminectomy. The improvement was statistically significant(P<0.05).
Emergencies
;
Follow-Up Studies
;
Humans
;
Laminectomy*
;
Neurologic Manifestations*
;
Paraplegia
4.A clinical study on the anti-hypertensive effect of fosinopril in essential hypertensive patients.
Su Youn NAM ; Jae Hwa CHO ; Joon Han SHIN ; Hyuck Moon KWON ; Yang Soo JANG ; Hyun Seung KIM
Korean Circulation Journal 1993;23(3):448-453
In order to investigate the efficacy and safety of oral fosinopril, a new phosphorus containing angiotensin converting enzyme inhibitor, a single dose of 10 to 20mg was administered in 23 hypertensive patients with diastotic blood pressure above 95mmHg and all other anti-hypertensive agents were not administered during 4 weeks of study. Blood pressure and heart rate were measured on the 2nd and 4th week of therapy. The complete blood count with platelet count, blood chemistry by SMA-12 and serum electrolytes were performed at the begining and 4th week of therapy. The urinalysis and electrocardiography were performed at the beginning and 4th week of therapy. Any kinds of side effects were actively questioned by the examining physicians. The following results were obtained : 1) At the beginning and 4th weeks of therapy, the average systolic and diastolic pressure were 170.0+/-17.6/101.6+/-6.1mmHg, 142.7+/-15.1/87.3+/-6.7mmHg respectively. The systolic and diastolic blood pressure were declined statistically significantly(p<0.05) throughout the period of treatment and diastolic blood pressure of all subjects except 3 patients(86%) was maintained below 90mmHg after 4th week of treatment. 2) There was no significant change in the pulse rate before and after therapy. 3) There were no significant changes in blood chemistry, serum electrolytes, hematologic findings, urinalysis and electrocardiographic findigns. 4) side effect were developed in 5 patients(23%) with dry cough, 3 patients(13%) with headache and 2 patients with facial edema but side effects were mostly mild in nature without potenitally serious episodes. These results suggested that antihypertensive therapy with onec-daily fosinopril was effective and well tolerated in essential hypertensive patients.
Antihypertensive Agents
;
Blood Cell Count
;
Blood Pressure
;
Chemistry
;
Cough
;
Edema
;
Electrocardiography
;
Electrolytes
;
Fosinopril*
;
Headache
;
Heart Rate
;
Humans
;
Hypertension
;
Peptidyl-Dipeptidase A
;
Phosphorus
;
Platelet Count
;
Urinalysis
5.Ewing's Sarcoma/PNET of the Talus: Report of a Case.
Sun Young KIM ; Hyuck Po KWON ; Jae Su ROH ; Hyoun Oh CHO
Korean Journal of Cytopathology 2004;15(2):120-125
Ewing's sarcoma (ES)/PNET is common in both axial and appendicular skeletons, but is extremely rare in the talus. Here, we report a case of ES/PNET of the left talus in a 29-year-old male patient diagnosed by fine needle aspiration cytology, and review the literature on similar cases. The cytological smears were composed of individually dispersed small round cells and occasional clusters of loosely cohesive cells. The tumor cells were fragile, frequently exhibiting naked nuclei. Two distinct types of cells were observed. The light (chief) cells displayed round or slightly oval nuclei with frequent indentations, generally inconspicuous nucleoli, and a thin rim of cytoplasm, which sometimes harbored small vacuoles. The dark cells were smaller, displaying scanty cytoplasm with dense hyperchromatic nuclei, intermixed with chief cells, and often manifesting as small molded groups. However, no significant nuclear pleomorphisms or mitoses were noted. Tumor cells in the cell block revealed positive cytoplasmic glycogen, as determined by a PAS stain with diastase control, and also exhibited positive immunoreactivity for CD99.
Adult
;
Amylases
;
Biopsy, Fine-Needle
;
Cytoplasm
;
Fungi
;
Glycogen
;
Humans
;
Male
;
Mitosis
;
Sarcoma, Ewing
;
Skeleton
;
Talus*
;
Vacuoles
6.Transcervical fallopian tube catheterization for proximal tubal obstruction.
Sung Il ROH ; Seo Ok KANG ; Hyuck Chan KWON ; Jung Hyun CHO ; Seung Jae LEE ; Jong Min PARK ; Do Yun LEE ; Byung Jae CHO
Korean Journal of Obstetrics and Gynecology 1992;35(7):1045-1053
No abstract available.
Catheterization*
;
Catheters*
;
Fallopian Tube Diseases*
;
Fallopian Tubes*
;
Female
7.Expression pattern of progesterone receptor, integrinbeta(3), cyclooxygenase-2 ( COX-2 ) in human endometrium of patient with the disease related implantation.
June Seo LEE ; Dong Wook PARK ; Hyuck Chan KWON ; Mi Ran KIM ; Kyoung Joo HWANG ; Hee Jae JOO ; Dong Jae CHO ; Sei Kwang KIM ; Kie Suk OH
Korean Journal of Obstetrics and Gynecology 2000;43(6):961-967
OBJECTIVE: We compared the expression pattern of progesterone receptor, integrin 3, cyclooxygenase-2 (COX-2) in in-phased endomerium of patient with the disease related implantation and control group, and tried to confirm the clinical efficacy of the immunohistochemical markers for discrimination of occult uterine receptivity defect in in-phase endometrium. STUDY DESIGN: Endometrial tissues were obtained from 60 women with normal (group 1; n = 20), uterine synechiae (group 2; n = 15), and endometriosis (group 3; n = 25). On 7 ~ 8 days after ovulation (POD 7 ~ 8), sex hormone levels were measured and immunohistochemical staining of PR, integrin 3, and COX-2 expression were performed. RESULTS: PR was decreased in the group 2 and increased in the group 3 comparing with the group 1. integrin 3 expression was significantly decreased in the group 2 and 3. COX-2 expression was significantly decreased in the group 2. But, in the group 3, COX-2 expression was slightly increased in glandular epithelial cells, and significantly increased in stromal cells. CONCLUSIONS: In-phase biopsies from patients with endometriosis and uterine synechiae showed different expression pattern of integrin 3, COX-2, and PR compared to the control. The aberrant expression of immunohistochemical markers be associated with occult uterine receptivity defect and produce the useful diagnostic method.
Biopsy
;
Cyclooxygenase 2*
;
Discrimination (Psychology)
;
Endometriosis
;
Endometrium*
;
Epithelial Cells
;
Female
;
Gynatresia
;
Humans*
;
Ovulation
;
Progesterone*
;
Receptors, Progesterone*
;
Stromal Cells
8.Sudden Hearing Loss in Chronic Myelogenous Leukemia Implicating Hyperviscosity Syndrome.
Sung Won CHAE ; Jae Hoon CHO ; Jang Hyuck LEE ; Soon Jae HWANG
Korean Journal of Otolaryngology - Head and Neck Surgery 2001;44(9):990-992
Sudden sensorineural hearing loss due to the initial manifestation of hematologic disease is very rare. Chronic myelogenous leukemia has been implicated as a causative factor of sudden sensorineural hearing loss. Leukemic infiltration, hemorrhage, infection, and hyperviscosity have been suggested as possible mechanisms in patients with chronic myelogenous leukemia. A 49-year-old male presented unilateral sudden sensorineural hearing loss. The patient was found to have chronic myelogenous leukemia during the work-up for the hearing loss. The WBC count upon admission was 485,100/mm(3). Hemoglobin, hematocrit, and platelet count were within the normal limits. The patient underwent three cycles of leukapheresis and chemotherapy with interferon alpha and hydroxyurea for the treatment of leukemia. The hearing threshold level was 75 dB on admission. It improved to 35 dB when the WBC count fell to 294,000/mm(3), and finally settled at 32 dB two weeks after the termination of chemotherapy when the WBC count was 125,900/mm(3). We present a case of a chronic myelogenous leukemia patient who initially presented with sudden sensorineural hearing loss. We presume that cochlear vessel occlusion as a result of elevated blood viscosity was responsible for this patient's hearing loss. Early onset of sudden deafness in a chronic myelogenous leukemia patient may be due to the hyperviscosity syndrome and be possible to reverse hearing loss through early leukapheresis.
Blood Viscosity
;
Drug Therapy
;
Hearing
;
Hearing Loss
;
Hearing Loss, Sensorineural
;
Hearing Loss, Sudden*
;
Hematocrit
;
Hematologic Diseases
;
Hemorrhage
;
Humans
;
Hydroxyurea
;
Interferon-alpha
;
Leukapheresis
;
Leukemia
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
;
Leukemic Infiltration
;
Male
;
Middle Aged
;
Platelet Count
9.3-Dimensional Culture System of Endometrial Cells for Studying the Human Implantation Mechanism.
Dong Wook PARK ; Hyun Won YANG ; Hyuck Chan KWON ; Ki Hong CHANG ; Sei Kwang KIM ; Dong Jae CHO ; Kie Suk OH
Korean Journal of Fertility and Sterility 1999;26(1):1-8
In order to study the implantation mechanism various methods for culture of endometrial cells in vitro have been attempted. However, a disadvantage is that primary cultures of stromal and epithelial cells do not have the ability to differentiate, and therefore cannot be reproduced in the same manner as in vivo endometrium. The object of this study is to establish a three dimensional culture of endometrial cells which are both morphologically and functionally identical to in vivo endometrium. Endometrial tissues obtained after hysterectomies were cut into thin slices and treated with collagenase and trypsin-EDTA. The stromal cells and the epithelial cells were separated by centrifugation and cultured for 24 hours in DMEM media containing 10% FCS, 100 nM progesterone, and 1 nM estradiol. The cultured stromal cells were mixed with collagen gel and solidified, after which it was covered with matrigel. Epithelial cells were inoculated on the top and then cultured for 3 days. The three dimensionally cultured endometrial cells were stained for integrin alphal, alpha4, beta3, and cyclooxygenase-1, -2 by immunohistochemistry, which all showed strong expression. The cultured epithelial cells showed the formation of microvilli, tight junctions and pinopodes by electron microscopy. Studies are currently under way utilizing this three dimensional culture model to ascertain the interaction between the embryo and human endometrial cells at the time of implantation, and it is thought that further studied into a new culture environment which would allow longer periods of culture will be necessary.
Antigens, CD11a
;
Centrifugation
;
Collagen
;
Collagenases
;
Cyclooxygenase 1
;
Embryonic Structures
;
Endometrium
;
Epithelial Cells
;
Estradiol
;
Female
;
Humans*
;
Hysterectomy
;
Immunohistochemistry
;
Microscopy, Electron
;
Microvilli
;
Progesterone
;
Stromal Cells
;
Tight Junctions
10.Synthesis and Biodistribution of Flumazenil Derivative F-18(3-(2-Fluoro) flumazenil for Imaging Benzodiazepine Receptor.
Sung Hyun HONG ; Jae Min JEONG ; Young Soo CHANG ; Dong Soo LEE ; June Key CHUNG ; Jung Hyuck CHO ; Sook Ja LEE ; Sam Sik KANG ; Myung Chul LEE
Korean Journal of Nuclear Medicine 1999;33(6):527-536
PURPOSE: Radiotracers that bind to the central benzodiazepine receptor are useful for the investigation of various neurological and psychiatric diseases. [C-11]Flumazenil, a benzodiazepine antagonist, is the most widely used radioligand for central benzodiazepine receptor imaging by PET. We synthesized 3-(2-[F- 18]fluoro)flumazenil, a new fluorine-18 (t1/2=110 min) labeled analogue of benzodiazepine receptor imaging agent, and evaluated in vivo for biodistribution in mice. MATERIALS AND METHODS: Flumazenil (Ro 15-1788) was synthesized by a modification of the reported method. Precursor of 3-(2-[F-18]fluoro)flumazenil, the tosylated flumazenil derivative was prepared by the tosylation of the ethyl ester by ditosylethane. [F-18] labeling of tosyl substitued flumazenil precursor was performed by adding F-18 ion at 85 degree C in the hot cell for 20 min. The reaction mixture was trapped by C18 cartridge, washed with 10% ethanol, and eluted by 40% ethanol. Bidistribution in mice was determined after intravenous injection. RESULTS: The total chemical yield of tosylated flumazenil derivative was ~40%. The efficiency of labeling 3-(2-[F-18]fluoro)flumazenil was 66% with a total synthesis time of 50 min. Brain uptakes of 3-(2-[F-18]fluoro)flumazenil at 10, 30, 60 min after injection, were 2.5+/-0.37, 2.2+/-0.26, 2.1+/-0.11 and blood activities were 3.7+/-0.43, 3.3+/-0.07, 3.3+/-0.09%ID/g, respectively. CONCLUSION: We synthesized a tosylated flumazenil derivative which was successfully labeled with no-carrier-added F-18 by nucleophilic substitution.
Animals
;
Benzodiazepines*
;
Brain
;
Ethanol
;
Flumazenil*
;
Injections, Intravenous
;
Mice
;
Receptors, GABA-A*